Stocktoria

Rocket One Inc. RKTO

Nasdaq · XNAS · stock · Pharmaceutical Preparations
Chart by TradingView
1/9
Piotroski F — financial health
Altman Z″ — distress risk
Dividend payout · no dividend

Financials & ratios (annual, from 10-K)

MetricFY2025FY2024FY2023FY2022FY2021
Financials
Operating income-$12.4M-$8.2M-$8.0M-$11.1M-$14.1M
Net income-$12.5M-$8.2M-$8.1M-$11.4M-$14.3M
Operating cash flow-$9.8M-$7.0M-$8.4M-$9.3M-$12.1M
Total assets$7.6M$7.7M$10.2M$7.7M$11.0M
Total liabilities$1.5M$833,906$704,983$1.6M$1.1M
Shareholders' equity$6.2M$6.9M$9.5M$6.1M$9.9M
Ratios
Return on assets-164.0%-106.2%-79.1%-146.9%-130.3%
Return on equity-202.7%-119.0%-85.0%-186.3%-144.8%
Current ratio4.729.2014.965.5612.19

Why these scores methodology →

Piotroski F-score: 1/9

  • Positive return on assets
  • Positive operating cash flow
  • Rising ROA
  • Cash flow exceeds net income
  • Lower long-term debt
  • Rising current ratio
  • No share dilution
  • Rising gross margin
  • Rising asset turnover

Altman Z″: n/a

Not applicable (financials/insurer or missing inputs).

Sector peers

VFS · TM · HMC · SONY · AAPL · XOM · all Manufacturing →

Source: SEC EDGAR filings · CIK 0001711786 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.